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A B S T R A C T
The aim of this study is to compare the effects of femoral analgesia (FA) with 0.25% levobupivacain and intravenous
patient controlled analgesia (PCA) with morphine on postoperative pain assessed by a visual-analog scale (VAS) score
and their complications during the first 24 postoperative hours after the a total knee arthroplasty in a prospective ran-
domized study. Secondary outcomes included: morphine use, patient satisfaction, complication of analgesia and dura-
tion of hospital stay. We analyzed 71 patients with an ASA score of II or III. The patients were randomized into two
groups: group PCA (n=36) was given the PCA pump, which contained morphine; and group FA (n=35) was given first a
bolus dose, then a continuous infusion 0.25% levobupivacain via a femoral catheter. The assessment of VAS was per-
formed every 2 hours. There were no differences between the PCA and FA groups regarding demographic characteristics,
operation duration, ASA score distribution, duration of hospital stay and satisfaction with analgesia (although there
were more satisfied patients in the FA group). Significant differences were noted in the quantity of morphine used
(higher values were in the PCA group; p<0.001). More complications were recorded in PCA group (p<0.001). The VAS
score was lower in the FA group (p<0.001). The highest difference occurred 4 hours after the operation, with the PCA
group having significantly higher VAS score values compared to the FA group. Femoral analgesia leads to a stronger
pain relief with less side effects, less morphine use andmore patient satisfaction than intravenous PCA with morphine.
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Introduction
The implantation of total knee prosthesis is deemed to
be one of the most painful procedures in orthopedic sur-
gery1. Inadequate control of postoperative pain is associ-
ated with poor patient recovery, longer rehabilitation, ex-
tended hospital stay and higher cost of treatment. Uncon-
trolled pain leads to hormonal-metabolic stress response as
well as to inflammatory response, which both have nega-
tive effects on other organ systems2. The patients who un-
dergo total knee arthroplasty are usually in the older age
group with a decreased cardiac reserve and incipient im-
pairments of other vital organ systems. This older age
group also has an increased sensitivity to medications19.
For postoperative analgesia, it is necessary to choose
the method and analgesic that has minimal side effects.
Postoperative analgesia is achieved using various meth-
ods, such as intravenous analgesia, patient controlled an-
algesia (PCA)3, central neural analgesia (epidural analge-
sia)4, and peripheral regional analgesia of the lumbar
plexus5. A multimodal approach of balanced analgesia
certainly has its place in orthopedic surgery6. Peripheral
regional analgesia is the method of choice for postopera-
tive analgesia after painful orthopedic surgery proce-
dures7. Unlike PCA, peripheral regional analgesia re-
quires that practitioners have appropriate experience.
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The aim of this randomized prospective study was to
compare the effects and complications of two analgesic
techniques: femoral nerve catheter analgesia and patient
control analgesia with morphin after the total knee ar-
throplasty (TKA).
The primary end point was the assessment of postop-
erative analgesia using the visual analog scale (VAS scor-
ing; 0=no pain, 10=worst pain) at rest and in motion.
Secondary end points included: morphine use, de-
grees of knee flexion on the second postoperative day
(2POD), patient satisfaction (satisfied or not satisfied)
with analgesia, complications of analgesia and duration
of hospital stay.
Materials and Methods
The Ethics Committee of the University of Trau-
matology Zagreb approved the study and all 80 patients
gave a written informed consent to participate. The 80
patients with ASA scores II and III were selected for the
elective TKA surgery in spinal anesthesia. The partici-
pants were randomized into two groups: group FA (44
patients) and group PCA (36 patients) using statistical
software MedCalc for Windows (v.11.0, www.medcalc.be).
Nine patients were excluded from the study because
their femoral catheter fell out (Figure 1).
In order to be excluded from the study, the patients
had to meet at least one the following criteria: previous
vascular surgery in the region of femoral veins or arter-
ies, confirmed coagulopathy, local infection, hepatic and
renal insufficiency, dementia, body mass index (BMI)
>30 kg/m2, allergy to local anesthetics, morphine and
non-steroid anti inflamatory drugs, a previously diag-
nosed neurologic deficit and an ASA score>III.
Standard monitoring was used throughout the proce-
dure (including noninvasive arterial blood pressure, elec-
trocardiography, heart rate and oxygen saturation).
The femoral catheter was set before the spinal anes-
thesia with patients in the supine position, with a nerve
stimulator (Stimuplex HNS 11,B.Braun,Germany) set to
deliver a stimulus at a frequency of 2Hz and duration of
0.1 ms. The intensity of the current, initially set to 1.2
mA, was gradually decreased to 0.3 mA (<0.5 mA) while
the stimulation of the femoral nerve was maintained.
The puncture site was located 5 cm caudal to the ingui-
nal ligament and one centimeter lateral to the femoral ar-
tery and then advanced in a lateral and posterior direction
just distal to the inguinal ligament. The femoral nerve was
identified by contractions of the quadriceps muscle, re-
ferred to as the »dancing« patella. The femoral nerve cathe-
ter was inserted from 5–10 cm beyond the tip of the needle
in a cephalad direction (Contiplex Tuohy 18G, B.Braun,
Germany). Fixation of the femoral catheter was performed
by LockIt Plus™ (Smiths; Catheter Securement Device).
One anesthesiologist who was trained in the tech-
niques of regional anesthesia set the femoral catether.
The time required for setting one femoral catheter was
10 minutes (median; interquartile range 8.5–10 min). All
the catheters were left in place for 48 hours.
The patients received premedication consisting of mi-
dazolam per os at a concentration of 0.1mg/kg. All pa-
tients were anesthetized using spinal anesthesia with
3mL of 0.5% levobupivacain in the region of L3/L4 or
L4/L5 segments. Intraoperatively, the patients were se-
dated with 2.5–5mg midazolam intravenous and fentanyl
in doses of 1–2ug/kg.
Data on baseline demographic characteristics (age,
sex), BMI and ASA score were collected. Furthermore,
the duration of surgical procedure and the duration of
tourniquet application were assessed.
After the sensory recovery from spinal anesthesia and
when the patients complained of pain, group FA was
given first a bolus dose of 8 ml 0.25%levobupivacain,
then 5–6 mL per hour of 0.25% levobupivacain via a fem-
oral catheter in addition to the intravenous dose of mor-
phine: 5mg (patient weight <60kg) or 10 mg (patient
weight >60 kg) if pain in the posterior part of the knee
was higher than 3 points. Group PCA was given the pa-
tient controlled analgesia (PCA) pump, which contained
morphine (concentration 1mg/ml; »basal rate« 3 mg/h,
bolus upon request 2 mg, with »lock out« interval of 8
minutes). Both groups received diclofenac 75 mg intrave-
nous every 12 hours. A VAS score of lower than or equal
to 3 was considered good analgesia.
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Fig. 1. CONSORT diagram: showing the flow of patient
throughout study.
The primary outcome was assessment of analgesia us-
ing VAS scoring (0=no pain; 10=worst pain). It was per-
formed within the first 24 postoperative hours, every 2
hours in resting position and during movement after the
reversion of spinal anesthesia during the patient’s stay
in the Intensive Care Unit (ICU). The assessment of the
level of sedation was done within the first 24 postopera-
tive hours by using the following scale: 1 – awake and ori-
ented; 2 – sleepy, responds to a call; 3 – responds to a call
with difficulties, but responds to painful stimuli.
We monitored: cardiovascular (heart rhythm disorders-
-supraventricular or ventricular disorders and hemody-
namic instability-drops of blood pressure of more the 20%
of starting values) and gastrointestinal (nausea, vomiting)
complications of analgesia during the first 24 postoperative
hours of each patient’s stay in the ICU; urinary retention;
patient satisfaction with analgesia (satisfied or not satis-
fied); morphine use; degrees of knee flexion on the second
postoperative day (2 POD); and duration of hospital stay.
The VAS scores were assessed by persons who were not in-
volved in setting the femoral nerve catheter.
Statistical methods
Power analyses were performed for repeated mea-
sures (power 0.95; Effect size dz 0.5; a error probability
0,05; two tailed) with minimal total samples of 35 partici-
pants per group.
Data were shown in tables and graphs. The Smirnov-
-Kolmogorov test was performed to analyze the quantita-
tive data distribution and the appropriate non-parametric
test (Mann-Whitney U test) was used to analyze differences
between group PCA and group FA. Related measures (dif-
ferences in VAS score over time) for both groups were as-
sessed with the Friedman test. Differences in categorical
data were analyzed with the chi-square test with a continu-
ity correction for 2x2 tables. All p values under 0.05 were
considered significant. Statistical analyses were performed
using MedCalc for Windows, version 11.0 (MedCalc Soft-
ware, Mariakerke, Belgium)
Results
The only non-significant difference in postoperative
VAS scores between the groups was observed 2 hours af-
ter operation. All other VAS scores in rest and motion
differ significantly (p<0.001). The highest difference is 4
hours after the operation when group PCA had signifi-
cantly higher VAS scores as compared to group FA (Table
1). Dynamics of VAS scores regarding measuring time
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TABLE 1
DIFFERENCES IN VAS SCORE IN REST AND MOTION BETWEEN PCA AND GROUP FA REGARDING TIME AFTER OPERATION:
MANN-WHITNEY U TEST
Group
PCA (N=36) FA (N=35)
pMedian
(interquartile range)
Median
(interquartile range)
VAS score after 2h: resting 2.0 (1.3–3.0) 2.0 (2.0–3.0) 0.238
VAS score after 4h: resting 7.0 (6.3–8.0) 3.0 (3.0–4.0) <0.001
VAS score after 6h: resting 5.0 (5.0–6.0) 4.0 (4.0–4.0) <0.001
VAS score after 8h: resting 5.0 (4.0–6.0) 4.0 (4.0–4.0) <0.001
VAS score after 10h: resting 5.0 (4.0–5.0) 4.0 (4.0–4.0) <0.001
VAS score after 12h: resting 4.0 (4.0–5.0) 3.0 (3.0–4.0) <0.001
VAS score after 14h: resting 4.0 (4.0–4.0) 2.0 (2.0–3.0) <0.001
VAS score after 16h: resting 4.0 (4.0–4.0) 2.0 (2.0–2.0) <0.001
VAS score after 18h: resting 4.0 (3.3–4.0) 2.0 (2.0–2.0) <0.001
VAS score after 20h: resting 3.0 (2.0–4.0) 2.0 (2.0–2.0) <0.001
VAS score after 24h: resting 3.0 (2.0–4.0) 2.0 (2.0–2.0) <0.001
VAS score after 2h: motion 2.5 (1.8–4.0) 2.0 (2.0–3.0) 0.125
VAS score after 4h: motion 8.0 (7.3–9.0) 4.0 (3.0–4.0) <0.001
VAS score after 6h: motion 6.0 (6.0–8.0) 4.0 (4.0–5.0) <0.001
VAS score after 8h: motion 6.0 (5.0–7.0) 5.0 (4.0–5.0) <0.001
VAS score after 10h: motion 5.0 (5.0–6.0) 4.0 (4.0–5.0) <0.001
VAS score after 12h: motion 5.0 (4.0–5.0) 3.0 (3.0–3.0) <0.001
VAS score after 14h: motion 5.0 (4.0–5.0) 3.0 (3.0–3.0) <0.001
VAS score after 16h: motion 4.0 (4.0–5.0) 3.0 (3.0–3.0) <0.001
VAS score after 18h:motion 4.0 (4.0–5.0) 2.0 (2.0–2.0) <0.001
VAS score after 20h: motion 4.0 (3.0–4.0) 2.0 (2.0–2.0) <0.001
VAS score after 24h: motion 4.0 (3.0–4.0) 2.0 (2.0–2.0) <0.001
VAS – visual analog scale, PCA – patient controlled analgesia, FA – femoral analgesia
and groups are shown in Figure 2 and 3. Changes in post-
operative values of VAS scores (from 2h to 24h) during
resting and motion were significant (p<0.001) in both
groups respectively.
There were no significant differences between group
PCA and group FA regarding age, BMI, gender and ASA
score distribution (Table 2); operation duration, duration
of hospitalisation. Significant differences were noted only
in the quantity of morphine used (higher values are in
group PCA; p<0.001) and in duration of tourniquet ap-
plication (longer use in group FA; p=0.013) (Table 3).
Significantly more complications were recorded in
group PCA (p<0.001): 28 (77.8%) patients had gastroin-
testinal symptoms (nausea and vomiting), 13 (18.3%)
had urinary retention, 21 (58.3%) had hemodynamic in-
stability and 32 (88.9%) patients were moderately and
highly sedated (response only to shouting or pain stimu-
lus). There was no significant difference in heart rhythm
disorders and in satisfaction with analgesia, although
there were more satisfied patients in Group FA. Active
motion (flexion over 60 degrees) occurred significantly
more often in group FA, p<0.001 (Table 2).
Discussion
Our results suggest that patients from group FA had
significantly lower VAS score (i.e. better postoperative
analgesia) within the first 24 postoperative hours both at
rest and in movement (Table 1), less morphine use and
less side effects or complications compared with group
PCA (Table 3). During the fourth postoperative hour the
difference in VAS score between the groups had the
greatest magnitude (Figure 2 and Figure 3). The use of
morphine in group FA was reduced by 60% within the
first 24 postoperative hours.
Results suggest that group PCA had a more heart
rhythm disorders (2.8%) because they have significantly
higher VAS scores and don’t have adequate/suitable pain
control. Morphine in combination with blood loss and
hypovolemia in early postoperative time can lead to
hemodinamic instabilility (group PCA 58.3%) and
hypotension. Group FA had a more efficient early reha-
bilitation than group PCA. Early rehabilitation and mo-
bilization after orthopedic surgical procedures is impor-
tant, but limited by strong postoperative pain and
muscular spasm19. Regional analgesic techniques con-
tribute to better analgesia and quicker postoperative
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TABLE 2
SOCIO – DEMOGRAPHIC CHARACTERISTICS: MANN-WHITNEY U TEST AND CHI-SQUARE TEST
Group
PCA
(N=36)
FA
(N=35)
p
Age (years): median (interquartile range) 70 (68–73) 69 (66–72) 0.358
Body mass index (kg/m2): median (interquartile range) 27.2 (25.0–29.0) 26.0 (24.5–27.3) 0.401
Female gender: N (%)* 18 (50.0%) 16 (45.7%) 0.901
ASA score III**: N (%)* 23 (63.9%) 16 (45.7%) 0.194
*c2-test with continuity correction for 2x2 table, **ASA score were only assessed as II or III
TABLE 3
CLINICAL DATA: MANN-WHITNEY U TEST AND CHI-SQUARE TEST
Group
PCA
(N=36)
FA
(N=35)
p
Operation duration (min): median (interquartile range) 90.0 (65.0–98.8) 90.0 (80.0–110.0) 0.248
»Tourniquet« duration (min): median (interquartile range) 72.5 (65.0–95.0) 85.0 (80.0–95.0) 0.013
Morphine: median (interquartile range) 40.0 (40.0–40.0) 15.0 (5.0–20.0) <0.001
Duration of hospitalisation (days): median (interquartile range) 12 (50.0%) 10 (45.7%) 0.891
Arrhythmias: N (%)* 2 (2.8%) 0 (0.0%) 0.486
Gastrointestinal complications: N (%)* 28 (77.8%) 0 (0.0%) <0.001
Urinary retention: N (%)* 13 (18.3%) 0 (0.0%) <0.001
Hemodynamic instability: N (%)* 21 (58.3%) 6 (17.1%) <0.001
Moderate and highly sedated: N (%)* 32 (88.9%) 0 (0.0%) <0.001
Satisfaction with analgesia: N (%)* 23 (65.7%) 29 (82.9%) 0.172
Flexion >60° (active motion,2 POD): N (%)* 10 (27.8%) 30 (85.7%) <0.001
rehabilitation8,19. There were no significant differences
in the hospital stay length between the groups (p=0.96).
despite better analgesia and less morphine use in group
FA. The length of hospital stay did not depend on better
or worse analgesia or on higher frequency of complica-
tions of analgesia. Nevertheless, it was associated with ti-
tration of the dose of oral anticoagulants and with early
postoperative rehabilitation. Moreover, a common prac-
tice in public hospitals in transitional countries with in-
adequate economic strategy is to keep patients in the
hospital for a rather long period of time, which may have
contributed to the length of hospital stay in this study.
Potential limitations9 of the femoral nerve block in-
clude toxicity of the local anesthetic and »block failure«.
»Secondary analgesic block failure« after a successful
block (migration of catheter or the top of catheter not be-
ing in the proximity of the nerve) is possible in the ranges
from 10%10 up to 40%11. The success of sensory and motor
blocks, as well as postoperative analgesia, depend on the
position of the catheter under the fascia iliaca.
We did not observe any catheter migrations within the
first 24 postoperative hours in our patients. However, the
position of the catheter was not checked by radiological
methods. We did not notice any complications in the sense of
toxic effect of local anesthetic or catheter related infections.
This study is subject to several methodological limita-
tions. Firstly, the femoral catheter was inserted using a
nerve stimulator, but without ultrasound control12,13 be-
cause our anesthesiology unit does not have an ultra-
sound machine. Secondly, the assessment of pain and
sensory analgesia was based on patients’ subjective as-
sessment using VAS score. We did not use the »pin prick
test« or other objective methods to estimate sensory an-
algesia. Analgesia was assessed only within the first 24
postoperative hours during each patients’ stay in the In-
tensive Care Unit which enabled adequate monitoring
and control. Even this would not have been feasible at
other hospital departments or units and consequently we
did not evaluate analgesia over a longer period
It is necessary to investigate if there are significant
differences in the intensity of analgesia and side-effects
with respect to the concentration and type of local anes-
thetic (0.125%, 0.25% or 0.375% levobupivacain vs. bupi-
vacain vs. ropivacain) in the elderly.
Femoral analgesia is significantly cheaper14 than intra-
venous PCAwithmorphine (1,200 _0length vs. 2,800 _0length per patient
in our study; the costs include the length of stay in the In-
tensive Care Unit, nurse’s and anesthesiologist’s work,
analgesia-related complications, the material for delivery
of analgesia PCA pump, nerve stimulator, femoral cathe-
ter and all the other devices) which is of great relevance
for health care in South Eastern Europe where scarce fi-
nancial resources dictate the choice of cheaper techniques
without deleterious consequences on patients’ health.
Conclusion
Femoral analgesia is an important part of multimodal
balanced analgesia after TKA. Peripheral regional anal-
gesia (peripheral nerve block) is a technique of choice for
the postoperative analgesia after painful orthopedic sur-
gery7,20. It contributes to a stronger analgesia and quicker
postoperative rehabilitation15 with less side-effects16, less
morphine use (»opiods sparing effect«)17, more patient
satisfaction and lower cost of treatment19. Our study con-
firmed the Procedure Specific Postoperative Pain Man-
agement (PROSPECT)18 protocol for analgesia after
TKA surgery
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Fig. 2. Changes in VAS score at resting regarding measurement
time.
Fig. 3. Changes in VAS score in motion regarding measurement
time.
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PERIFERNA REGIONALA ANALGEZIJA VERSUS INTRAVENOZA »PATIENT CONTROLLED«
ANALGEZIJA NAKON UGRADNJE TOTALNE PROTEZE KOLJENA: PROSPEKTIVNA,
RANDOMIZIRANA STUDIJA
S A @ E T A K
Cilj ove prospektivne, randomizirane studije je usporediti u~inak femoralne analgezije (FA) 0,25% levobupivaka-
inom i intavenozne »patient controlled« analgezije (PCA) morphinom na ishod poslijeoperacijske bol, kao i njihove
komplikacije 24 h nakon ugradnje totalne proteze koljena. Sekundarni cilj uklju~uje: razliku u potro{nji morphina po
grupama, zadovoljstvo bolesnika analgezijom, komplikacije analgezije, trajanje hospitalizacije. Analizirali smo 71 bo-
lesnika, ASA II i III skora. Bolesnici su randomizirani u dvije grupe: grupa PCA (n=36) je analgezirana intravenoznom
PCA morphinom; grupa FA (n=36) je analgezirana preko femoralnog katetera kontinuiranom infuzijom 0,25% levo-
bupivakainom. Procjena VAS boli je vr{ena svaka 2 sata u mirovanju i pokretu. Nije bilo statisti~ki zna~ajne razlike
me|u grupama u demografskim karakteristikama, trajanju operacije, ASA distribuciji, trajanju hospitalizacije i zado-
voljstvu analgezijom (premda je grupa FA bila zadovoljnija). Statisti~ki zna~ajna razlika je bila u potro{nji morphina
(ve}a potro{nja kod PCA grupe; p<0,001). Vi{e komplikacije je bilo u grupi PCA (p<0,001). VAS je bio ni`i u grupi FA
(p<0,001). Najve}a razlika u VAS-u je bila 4 sata nakon operacije; grupa PCA je imala signifikantno ve}i VAS nego
grupa FA. Femoralna analgezija doprinosi boljoj kontroli boli sa manje nuspojava, manjom potro{njom morphina i ve-
}im zadovoljstvom bolesnika nego intravenozna PCA sa morphinom.
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